Literature DB >> 27031817

Estimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak--Puerto Rico, 2016.

Naomi K Tepper, Howard I Goldberg, Manuel I Vargas Bernal, Brenda Rivera, Meghan T Frey, Claritsa Malave, Christina M Renquist, Nabal Jose Bracero, Kenneth L Dominguez, Ramon E Sanchez, Carrie K Shapiro-Mendoza, Blanca R Cuevas Rodriguez, Regina M Simeone, Nicki T Pesik, Wanda D Barfield, Jean Y Ko, Romeo R Galang, Janice Perez-Padilla, Kara N D Polen, Margaret A Honein, Sonja A Rasmussen, Denise J Jamieson.   

Abstract

Zika virus is a flavivirus transmitted primarily by Aedes species mosquitoes. Increasing evidence links Zika virus infection during pregnancy to adverse pregnancy and birth outcomes, including pregnancy loss, intrauterine growth restriction, eye defects, congenital brain abnormalities, and other fetal abnormalities. The virus has also been determined to be sexually transmitted. Because of the potential risks associated with Zika virus infection during pregnancy, CDC has recommended that health care providers discuss prevention of unintended pregnancy with women and couples who reside in areas of active Zika virus transmission and do not want to become pregnant. However, limitations in access to contraception in some of these areas might affect the ability to prevent an unintended pregnancy. As of March 16, 2016, the highest number of Zika virus disease cases in the United States and U.S. territories were reported from Puerto Rico. The number of cases will likely rise with increasing mosquito activity in affected areas, resulting in increased risk for transmission to pregnant women. High rates of unintended and adolescent pregnancies in Puerto Rico suggest that, in the context of this outbreak, access to contraception might need to be improved. CDC estimates that 138,000 women of reproductive age (aged 15-44 years) in Puerto Rico do not desire pregnancy and are not using one of the most effective or moderately effective contraceptive methods, and therefore might experience an unintended pregnancy. CDC and other federal and local partners are seeking to expand access to contraception for these persons. Such efforts have the potential to increase contraceptive access and use, reduce unintended pregnancies, and lead to fewer adverse pregnancy and birth outcomes associated with Zika virus infection during pregnancy. The assessment of challenges and resources related to contraceptive access in Puerto Rico might be a useful model for other areas with active transmission of Zika virus.

Entities:  

Mesh:

Year:  2016        PMID: 27031817     DOI: 10.15585/mmwr.mm6512e1

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  18 in total

1.  Contraception as a Medical Countermeasure to Reduce Adverse Outcomes Associated With Zika Virus Infection in Puerto Rico: The Zika Contraception Access Network Program.

Authors:  Lisa Romero; Lisa M Koonin; Lauren B Zapata; Stacey Hurst; Zipatly Mendoza; Eva Lathrop
Journal:  Am J Public Health       Date:  2018-09       Impact factor: 9.308

2.  EPIDEMIOLOGY. Countering the Zika epidemic in Latin America.

Authors:  Neil M Ferguson; Zulma M Cucunubá; Ilaria Dorigatti; Gemma L Nedjati-Gilani; Christl A Donnelly; Maria-Gloria Basáñez; Pierre Nouvellet; Justin Lessler
Journal:  Science       Date:  2016-07-14       Impact factor: 47.728

3.  Commentary on Obstetric Care in Rural Georgia.

Authors:  Roger W Rochat
Journal:  Matern Child Health J       Date:  2016-07

4.  Community Perspectives on Contraception in the Context of the Zika Virus in the U.S. Virgin Islands: Implications for Communication and Messaging.

Authors:  Anna W Brittain; Euna M August; Lisa Romero; Margaret Sheahan; Jamie Krashin; Charity Ntansah; Margaret A Honein; Denise J Jamieson; Esther M Ellis; Michelle S Davis; Eva Lathrop
Journal:  Womens Health Issues       Date:  2019-03-13

5.  The Role of Public-Private Partnerships to Increase Access to Contraception in an Emergency Response Setting: The Zika Contraception Access Network Program.

Authors:  Lisa Romero; Zipatly V Mendoza; Laura Croft; Reema Bhakta; Turquoise Sidibe; Nabal Bracero; Claritsa Malave; Alicia Suarez; Linette Sanchez; Darielys Cordero; Eva Lathrop; Judith Monroe
Journal:  J Womens Health (Larchmt)       Date:  2020-11       Impact factor: 2.681

6.  Strategies and safeguards to ensure access to long-acting reversible contraception removal after the Zika Contraception Access Network ended: A prospective analysis of patient reported complaints.

Authors:  Lisa Romero; Zipatly Mendoza; Stacey Hurst; Lauren B Zapata; Rachel Powell; Yari Vale; Eva Lathrop
Journal:  Contraception       Date:  2020-08-25       Impact factor: 3.375

7.  Zika virus epidemic in Puerto Rico: Health justice too long delayed.

Authors:  Carlos E Rodríguez-Díaz; Adriana Garriga-López; Souhail M Malavé-Rivera; Ricardo L Vargas-Molina
Journal:  Int J Infect Dis       Date:  2017-11-15       Impact factor: 3.623

8.  Assessment of Contraceptive Needs and Improving Access in the U.S.-Affiliated Pacific Islands in the Context of Zika.

Authors:  Caitlin Green; Charity Ntansah; Meghan T Frey; Jamie W Krashin; Eva Lathrop; Lisa Romero
Journal:  J Womens Health (Larchmt)       Date:  2020-02       Impact factor: 2.681

9.  Program Fidelity and Patient Satisfaction among Women Served by the Zika Contraception Access Network Program in Puerto Rico.

Authors:  Lauren B Zapata; Lisa Romero; Maria I Rivera; Stephanie K Rivera-Soto; Stacey Hurst; Zipatly V Mendoza; Heather B Clayton; Nabal Bracero; Maura K Whiteman; Eva Lathrop
Journal:  Womens Health Issues       Date:  2020-05-04

10.  Impact of a Health Communication Campaign on Uptake of Contraceptive Services during the 2016-2017 Zika Virus Outbreak in Puerto Rico.

Authors:  Euna M August; Rachel Powell; Elana Morris; Lisa Romero; Lauren B Zapata; Eva Lathrop
Journal:  Health Commun       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.